Logo image of BXC

BLUELINX HOLDINGS INC (BXC) Stock Fundamental Analysis

USA - NYSE:BXC - US09624H2085 - Common Stock

75.89 USD
-2.47 (-3.15%)
Last: 9/19/2025, 8:04:01 PM
75.89 USD
0 (0%)
After Hours: 9/19/2025, 8:04:01 PM
Fundamental Rating

4

BXC gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 50 industry peers in the Trading Companies & Distributors industry. BXC has only an average score on both its financial health and profitability. BXC is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

BXC had positive earnings in the past year.
In the past year BXC had a positive cash flow from operations.
BXC had positive earnings in each of the past 5 years.
In the past 5 years BXC always reported a positive cash flow from operatings.
BXC Yearly Net Income VS EBIT VS OCF VS FCFBXC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

1.2 Ratios

BXC has a worse Return On Assets (1.79%) than 62.00% of its industry peers.
Looking at the Return On Equity, with a value of 4.57%, BXC is in line with its industry, outperforming 42.00% of the companies in the same industry.
The Return On Invested Capital of BXC (3.08%) is worse than 70.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BXC is in line with the industry average of 10.22%.
The 3 year average ROIC (11.49%) for BXC is well above the current ROIC(3.08%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 1.79%
ROE 4.57%
ROIC 3.08%
ROA(3y)8.8%
ROA(5y)11.32%
ROE(3y)22.02%
ROE(5y)56.9%
ROIC(3y)11.49%
ROIC(5y)14.44%
BXC Yearly ROA, ROE, ROICBXC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300

1.3 Margins

BXC has a Profit Margin of 0.96%. This is in the lower half of the industry: BXC underperforms 62.00% of its industry peers.
In the last couple of years the Profit Margin of BXC has declined.
BXC's Operating Margin of 2.09% is on the low side compared to the rest of the industry. BXC is outperformed by 72.00% of its industry peers.
In the last couple of years the Operating Margin of BXC has grown nicely.
Looking at the Gross Margin, with a value of 15.94%, BXC is doing worse than 88.00% of the companies in the same industry.
BXC's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 2.09%
PM (TTM) 0.96%
GM 15.94%
OM growth 3Y-33.48%
OM growth 5Y28.68%
PM growth 3Y-36.19%
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y4.13%
BXC Yearly Profit, Operating, Gross MarginsBXC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BXC is creating some value.
Compared to 1 year ago, BXC has less shares outstanding
BXC has less shares outstanding than it did 5 years ago.
The debt/assets ratio for BXC has been reduced compared to a year ago.
BXC Yearly Shares OutstandingBXC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
BXC Yearly Total Debt VS Total AssetsBXC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

BXC has an Altman-Z score of 3.49. This indicates that BXC is financially healthy and has little risk of bankruptcy at the moment.
BXC has a Altman-Z score of 3.49. This is in the better half of the industry: BXC outperforms 62.00% of its industry peers.
A Debt/Equity ratio of 0.96 indicates that BXC is somewhat dependend on debt financing.
BXC has a Debt to Equity ratio of 0.96. This is in the lower half of the industry: BXC underperforms 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF N/A
Altman-Z 3.49
ROIC/WACC0.33
WACC9.26%
BXC Yearly LT Debt VS Equity VS FCFBXC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 4.55 indicates that BXC has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 4.55, BXC belongs to the top of the industry, outperforming 94.00% of the companies in the same industry.
A Quick Ratio of 2.94 indicates that BXC has no problem at all paying its short term obligations.
BXC's Quick ratio of 2.94 is amongst the best of the industry. BXC outperforms 96.00% of its industry peers.
Industry RankSector Rank
Current Ratio 4.55
Quick Ratio 2.94
BXC Yearly Current Assets VS Current LiabilitesBXC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

3

3. Growth

3.1 Past

BXC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -63.76%.
BXC shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -40.26% yearly.
The Revenue has decreased by -2.32% in the past year.
Measured over the past years, BXC shows a small growth in Revenue. The Revenue has been growing by 2.28% on average per year.
EPS 1Y (TTM)-63.76%
EPS 3Y-40.26%
EPS 5YN/A
EPS Q2Q%-58.33%
Revenue 1Y (TTM)-2.32%
Revenue growth 3Y-11.62%
Revenue growth 5Y2.28%
Sales Q2Q%1.53%

3.2 Future

Based on estimates for the next years, BXC will show a very negative growth in Earnings Per Share. The EPS will decrease by -24.98% on average per year.
The Revenue is expected to grow by 2.90% on average over the next years.
EPS Next Y-76.57%
EPS Next 2Y-24.98%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.35%
Revenue Next 2Y2.9%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BXC Yearly Revenue VS EstimatesBXC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B 4B
BXC Yearly EPS VS EstimatesBXC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2019 2020 2021 2022 2023 2024 2025 2026 0 10 20 30

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 21.50, which indicates a rather expensive current valuation of BXC.
The rest of the industry has a similar Price/Earnings ratio as BXC.
When comparing the Price/Earnings ratio of BXC to the average of the S&P500 Index (27.38), we can say BXC is valued slightly cheaper.
With a Price/Forward Earnings ratio of 21.14, BXC is valued on the expensive side.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BXC is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.86, BXC is valued at the same level.
Industry RankSector Rank
PE 21.5
Fwd PE 21.14
BXC Price Earnings VS Forward Price EarningsBXC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BXC is valued a bit cheaper than the industry average as 78.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.5
BXC Per share dataBXC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 100 200 300

4.3 Compensation for Growth

A cheap valuation may be justified as BXC's earnings are expected to decrease with -24.98% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-24.98%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

BXC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BLUELINX HOLDINGS INC

NYSE:BXC (9/19/2025, 8:04:01 PM)

After market: 75.89 0 (0%)

75.89

-2.47 (-3.15%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)07-29 2025-07-29/amc
Earnings (Next)10-27 2025-10-27/amc
Inst Owners95.61%
Inst Owner Change-4.96%
Ins Owners2.21%
Ins Owner Change0.56%
Market Cap598.77M
Analysts77.5
Price Target83.64 (10.21%)
Short Float %6.05%
Short Ratio3.87
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-11.89%
Min EPS beat(2)-24.67%
Max EPS beat(2)0.88%
EPS beat(4)3
Avg EPS beat(4)13.48%
Min EPS beat(4)-24.67%
Max EPS beat(4)61.56%
EPS beat(8)6
Avg EPS beat(8)23.04%
EPS beat(12)8
Avg EPS beat(12)14.37%
EPS beat(16)12
Avg EPS beat(16)22.17%
Revenue beat(2)0
Avg Revenue beat(2)-1.43%
Min Revenue beat(2)-1.64%
Max Revenue beat(2)-1.23%
Revenue beat(4)1
Avg Revenue beat(4)-1.24%
Min Revenue beat(4)-2.52%
Max Revenue beat(4)0.42%
Revenue beat(8)2
Avg Revenue beat(8)-2.07%
Revenue beat(12)2
Avg Revenue beat(12)-3.74%
Revenue beat(16)6
Avg Revenue beat(16)-0.03%
PT rev (1m)0%
PT rev (3m)-10.14%
EPS NQ rev (1m)-25.58%
EPS NQ rev (3m)-48.49%
EPS NY rev (1m)-51.91%
EPS NY rev (3m)-51.91%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.9%
Revenue NY rev (1m)-0.73%
Revenue NY rev (3m)-1.34%
Valuation
Industry RankSector Rank
PE 21.5
Fwd PE 21.14
P/S 0.2
P/FCF N/A
P/OCF 30.18
P/B 0.96
P/tB 1.11
EV/EBITDA 8.5
EPS(TTM)3.53
EY4.65%
EPS(NY)3.59
Fwd EY4.73%
FCF(TTM)-3.02
FCFYN/A
OCF(TTM)2.51
OCFY3.31%
SpS373.54
BVpS78.75
TBVpS68.56
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.79%
ROE 4.57%
ROCE 4.59%
ROIC 3.08%
ROICexc 4.33%
ROICexgc 4.73%
OM 2.09%
PM (TTM) 0.96%
GM 15.94%
FCFM N/A
ROA(3y)8.8%
ROA(5y)11.32%
ROE(3y)22.02%
ROE(5y)56.9%
ROIC(3y)11.49%
ROIC(5y)14.44%
ROICexc(3y)16.25%
ROICexc(5y)17.76%
ROICexgc(3y)18%
ROICexgc(5y)19.38%
ROCE(3y)17.1%
ROCE(5y)21.48%
ROICexcg growth 3Y-37.08%
ROICexcg growth 5Y30.14%
ROICexc growth 3Y-37.9%
ROICexc growth 5Y30.02%
OM growth 3Y-33.48%
OM growth 5Y28.68%
PM growth 3Y-36.19%
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y4.13%
F-Score3
Asset Turnover1.86
Health
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF N/A
Debt/EBITDA 6
Cap/Depr 115.37%
Cap/Sales 1.48%
Interest Coverage 1.33
Cash Conversion 19.97%
Profit Quality N/A
Current Ratio 4.55
Quick Ratio 2.94
Altman-Z 3.49
F-Score3
WACC9.26%
ROIC/WACC0.33
Cap/Depr(3y)106.72%
Cap/Depr(5y)76.81%
Cap/Sales(3y)1.01%
Cap/Sales(5y)0.7%
Profit Quality(3y)260.74%
Profit Quality(5y)177.95%
High Growth Momentum
Growth
EPS 1Y (TTM)-63.76%
EPS 3Y-40.26%
EPS 5YN/A
EPS Q2Q%-58.33%
EPS Next Y-76.57%
EPS Next 2Y-24.98%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.32%
Revenue growth 3Y-11.62%
Revenue growth 5Y2.28%
Sales Q2Q%1.53%
Revenue Next Year1.35%
Revenue Next 2Y2.9%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-48.23%
EBIT growth 3Y-41.21%
EBIT growth 5Y31.62%
EBIT Next Year-5.4%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-105.85%
FCF growth 3Y-29.86%
FCF growth 5YN/A
OCF growth 1Y-95.59%
OCF growth 3Y-16.25%
OCF growth 5YN/A